Roy E Strowd1, Maja Herco2, Leah Passmore-Griffin3, Bradley Avery1, Ihtsham Haq1, Stephen B Tatter4, Jessica Tate1, Mustafa S Siddiqui5. 1. Department of Neurology, Wake Forest School of Medicine, Winston Salem, NC 27103, USA. 2. East Carolina School of Medicine, Greenville, NC, USA. 3. Department of Biostatistical Sciences, Division of Public Health Sciences, Wake Forest University Health Sciences, Winston Salem, NC 27103, USA. 4. Department of Neurosurgery, Wake Forest School of Medicine, Winston Salem, NC 27103, USA. 5. Department of Neurology, Wake Forest School of Medicine, Winston Salem, NC 27103, USA. Electronic address: mssiddiq@wakehealth.edu.
Abstract
OBJECTIVE: To evaluate whether weight change in patients with Parkinson's disease (PD) is different in those undergoing deep brain stimulation (DBS) of the subthalamic nucleus (STN) compared to those not undergoing DBS. PATIENTS AND METHODS: A retrospective case-control study was performed in PD patients who had undergone STN DBS (cases) compared to matched PD patients without DBS (controls). Demographic and clinical data including Unified Parkinson's Disease Rating Scale (UPDRS) motor scores were collected. Repeated measures mixed model regression was used to identify variables associated with weight gain. RESULTS: Thirty-five cases and 34 controls were identified. Baseline age, gender, diagnosis and weight were similar. Duration of diagnosis was longer in cases (6.3 vs 4.9 years, p=0.0015). At 21.3 months, cases gained 2.9 kg (+4.65%) while controls lost 1.8 kg (-3.05%, p<0.02). Postoperative UPDRS motor scores improved by 49% indicating surgical efficacy. Only younger age (p=0.0002) and DBS (p=0.008) were significantly associated with weight gain. CONCLUSION: In this case-control study, PD patients undergoing STN DBS experienced post-operative weight gain that was significantly different from the weight loss observed in non-DBS PD controls. Patients, especially overweight individuals, should be informed that STN DBS can result in weight gain.
OBJECTIVE: To evaluate whether weight change in patients with Parkinson's disease (PD) is different in those undergoing deep brain stimulation (DBS) of the subthalamic nucleus (STN) compared to those not undergoing DBS. PATIENTS AND METHODS: A retrospective case-control study was performed in PDpatients who had undergone STN DBS (cases) compared to matched PDpatients without DBS (controls). Demographic and clinical data including Unified Parkinson's Disease Rating Scale (UPDRS) motor scores were collected. Repeated measures mixed model regression was used to identify variables associated with weight gain. RESULTS: Thirty-five cases and 34 controls were identified. Baseline age, gender, diagnosis and weight were similar. Duration of diagnosis was longer in cases (6.3 vs 4.9 years, p=0.0015). At 21.3 months, cases gained 2.9 kg (+4.65%) while controls lost 1.8 kg (-3.05%, p<0.02). Postoperative UPDRS motor scores improved by 49% indicating surgical efficacy. Only younger age (p=0.0002) and DBS (p=0.008) were significantly associated with weight gain. CONCLUSION: In this case-control study, PDpatients undergoing STN DBS experienced post-operative weight gain that was significantly different from the weight loss observed in non-DBS PD controls. Patients, especially overweight individuals, should be informed that STN DBS can result in weight gain.
Authors: Roberta Balestrino; Damiano Baroncini; Mario Fichera; Carmine Antonio Donofrio; Alberto Franzin; Pietro Mortini; Giancarlo Comi; Maria Antonietta Volontè Journal: Neurol Sci Date: 2017-09-14 Impact factor: 3.307
Authors: Jacek Wilczyński; Agnieszka Pedrycz; Dariusz Mucha; Tadeusz Ambroży; Dawid Mucha Journal: Biomed Res Int Date: 2017-06-27 Impact factor: 3.411